MedPath

se of Vitamin D supplementation on BP control in Vitamin D deficient patients.

Not Applicable
Conditions
Health Condition 1: I10-I16- Hypertensive diseasesHealth Condition 2: E559- Vitamin D deficiency, unspecified
Registration Number
CTRI/2018/12/016734
Lead Sponsor
Adwaetha Nambiar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Induviduals with hypertension (newly diagnosed or on mono or dual therapy

2.vitamin D deficient

Exclusion Criteria

1.patients not willing to give consent

2.incomplete follow up data

3.patients on more than two antihypertensive medication

4.patients who are not tested for vitamin d deficiency.

5. patients who are already o vitamin D supplementation for a period of more than a month .

6. Patient expired during the study period

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
BPTimepoint: on the day of enrollment and after 8 weeks when patient comes for followup
Secondary Outcome Measures
NameTimeMethod
urea , serum creatinine,sodium, potassium , calciumTimepoint: on the day of enrollment and after 8 weeks
© Copyright 2025. All Rights Reserved by MedPath